Steve West - Gilead Sciences | 人才画像

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 11 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Effect of Food Intake or Coadministration with an Acid-Reducing Agent on Lenacapavir Pharmacokinetics Following Oral Administration

Renu Singh, Mark Shelton, Isabel Olson,John Ling,Steve West, Jeffrey A. Levy,Martin S. Rhee,Sandhya Girish,Ramesh Palaparthy

CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT（2025）

Cited0Views0WOSBibtex

The Effect of P-glycoprotein, Breast Cancer Resistance Protein and CYP3A4 Modulators on the Pharmacokinetics of the TLR-7 Agonist Vesatolimod in People Living with HIV

Yanan Zheng, Mary Wire, Buyun Chen, Christiaan de Vries, Olayemi Oisyemi, Kimberly Cruz, Howard Hassman, Juan Rondon,Daina Lim,Steve West,Jia Hao,Yiding Hu,Yurong Lai,Ramesh Palaparthy

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY（2024）

Cited0Views0Bibtex

Pharmacokinetics of Long-Acting Lenacapavir in Participants with Hepatic or Renal Impairment

Vamshi Jogiraju,Elijah Weber,Jason Hindman,Steve West,John Ling,Martin Rhee,Sandhya Girish,Ramesh Palaparthy,Renu Singh

ANTIMICROBIAL AGENTS AND CHEMOTHERAPYno. 4 (2024)

Cited2Views0WOSBibtex

Confirmation of the Drug–drug Interaction Potential Between Cobicistat-boosted Antiretroviral Regimens and Hormonal Contraceptives

Sophia R. Majeed,Steve West,Kah Hiing Ling,Moupali Das,Brian P. Kearney

Antiviral Therapy（2018）

Cited6Views0WOSBibtex

Lack of Clinically Relevant Effect of Bictegravir (BIC, B) on Metformin (MET) Pharmacokinetics (PK) and Pharmacodynamics (PD)

Joseph Custodio,Steve West, Amanda Yu,Hal Martin,Hiba Graham,Erin Quirk,Brian Kearney

Open Forum Infectious Diseasesno. suppl_1 (2017)

Cited10Views0Bibtex

Evaluation of the drug-drug interaction (DDI) potential between elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide and atorvastatin

Joseph Custodio,Steve West,Devi Sengupta, Arian Zari,Rita Humeniuk,Kah Hiing Ling,Marshall Fordyce,Brian Kearney

JOURNAL OF THE INTERNATIONAL AIDS SOCIETY（2016）

Cited0Views0Bibtex

SAFETY, PHARMACOKINETICS, AND ANTIVIRAL ACTIVITY OF SINGLE ORAL DOSES OF THE HCV NS3 PROTEASE INHIBITOR GS 9256

R. Goldwater,Michael P. DeMicco,Jian Zong, Greg E. Chittick,Geoffrey J. Yuen,Steve West, John Kagel,Andrew Bae,Hongmei Mo,David Oldach,William E. Delaney,John W. Findlay

HEPATOLOGY（2010）

Cited2Views0Bibtex

DUAL, TRIPLE, AND QUADRUPLE COMBINATION TREATMENT WITH A PROTEASE INHIBITOR (GS-9256) AND A POLYMERASE INHIBITOR (GS-9190) ALONE AND IN COMBINATION WITH RIBAVIRIN (RBV) OR PEGIFN/RBV FOR UP TO 28 DAYS IN TREATMENT NAiVE, GENOTYPE 1 HCV SUBJECTS

Stefan Zeuzem,Peter Buggisch,Kosh Agarwal,Michael P. Manns, Patrick Marcellins,Graham R. Foster,Daniel Sereni,Hartwig Klinker,Christophe Moreno,Jean Pierre H. Zarski,Mark J. Shelton,Steve West,Jian Zong,Jeanette Harris,John G. McHutchison,William Lee,William E. Delaney,David Oldach

HEPATOLOGY（2010）

Cited7Views0Bibtex

Pharmacokinetic Interaction of Ritonavir-Boosted Elvitegravir and Maraviroc

Srinivasan Ramanathan,Samantha Abel,Sarah Tweedy,Steve West,James Hui,Brian P. Kearney

JAIDS Journal of Acquired Immune Deficiency Syndromes（2010）

Cited26Views0WOSBibtex

Pharmacokinetics and Bioavailability of an Integrase and Novel Pharmacoenhancer-Containing Single-Tablet Fixed-Dose Combination Regimen for the Treatment of HIV

Polina German,David Warren,Steve West,James Hui,Brian P. Kearney

JAIDS Journal of Acquired Immune Deficiency Syndromes（2010）

Cited90Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn